Prochlorperazine

丙氯拉嗪

Report date: 2026/03/30 17:02:26

Base Information

Drug NameProchlorperazine
Drug Alias Name甲哌氯丙嗪proclorperazina丙氯比拉嗪prochlorperazinum普氯拉嗪 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaBipolar DisorderAnxiety +[6] 
Global Approved IndicationsSchizophreniaBipolar DisorderAnxiety +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1973/02/22
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesAventis Pharma Ltd
Inactive CompaniesN/A
Active IndicationsSchizophreniaBipolar DisorderAnxiety +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN05AB04
Related LinksWikipediaDrugBankKEGG